|
29/10/2025
|
07:05
|
Transaction in Own Shares
|
RNS
|
|
29/10/2025
|
07:00
|
3rd Quarter Results
|
RNS
|
|
28/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
28/10/2025
|
07:00
|
GSK ADC gets orphan drug designation in the EU
|
RNS
|
|
27/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
24/10/2025
|
07:00
|
Blenrep approved by US FDA in multiple myeloma
|
RNS
|
|
24/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
23/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
22/10/2025
|
07:05
|
Positive data for low carbon version Ventolin MDI
|
RNS
|
|
22/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
22/10/2025
|
07:00
|
Latozinemab data read out
|
RNS
|
|
21/10/2025
|
07:05
|
Positive CHMP Opinion for GSK on Shingrix PFS
|
RNS
|
|
21/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
21/10/2025
|
07:00
|
GSK share positive Ph3 data on tebipenem HBr
|
RNS
|
|
20/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
17/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
16/10/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
|
16/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
15/10/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
|
15/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
14/10/2025
|
07:00
|
GSK receives expanded Shingrix approval in China
|
RNS
|
|
14/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
13/10/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
|
13/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
10/10/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
|
10/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
09/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
08/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
07/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
06/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
03/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
02/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
01/10/2025
|
15:00
|
Total Voting Rights
|
RNS
|
|
01/10/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
30/09/2025
|
07:00
|
GSK - third tranche of share buyback programme
|
RNS
|
|
29/09/2025
|
07:00
|
GSK appoints CEO designate
|
RNS
|
|
22/09/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
|
19/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
18/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
17/09/2025
|
07:00
|
GSK US Investment Announcement
|
RNS
|
|
17/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
16/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
15/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
12/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
11/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
10/09/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
|
10/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
09/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
08/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
|
05/09/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|